An Unbiased View of Abbreviated New Drug Application (ANDA)
(ii) In Phases 2 and 3, in depth protocols describing all aspects of the review must be submitted. A protocol for the Section two or 3 investigation need to be developed in this type of way that, In the event the sponsor anticipates that some deviation with the review structure may possibly come to be needed as being the investigation progresses, c